NASDAQ:KTRA
Delisted

Kintara Therapeutics Stock Predictions

etoro logo Buy KTRA
*Your capital is at risk
$0.215
+0 (+0%)
At Close: Jan 16, 2025
Currently predicting for Fri, 5 Jun 2026

KTRA Prediction Chart

KTRA Predictions History

Latest community submissions for KTRA.
Predictor Target Session Target Price Result Direction Accuracy Score
Mar 5, 2024 $0.0989 +4.03% $0.102 V 96.61% 1
Mar 5, 2024 Bullish $0.102 V 1
JS JS Pro
Feb 23, 2024 $0.100 +4.38% $0.0912 X 90.35% 0
AlexVel AlexVel Pro
Feb 23, 2024 $0.0941 -1.75% $0.0912 V 96.80% 1
Feb 23, 2024 $0.103 +7.45% $0.0912 X 87.13% 0
Feb 23, 2024 $0.100 +4.66% $0.0912 X 90.06% 0
JS JS Pro
Feb 22, 2024 $0.0860 -8.22% $0.0958 X 89.77% 0
Feb 22, 2024 $0.101 +7.81% $0.0958 V 94.56% 1
Feb 22, 2024 $0.0983 +4.88% $0.0958 V 97.42% 1
JS JS Pro
Feb 20, 2024 $0.0940 -4.08% $0.0980 X 95.92% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for KTRA with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT KINTARA THERAPEUTICS INC.
Kintara Therapeutics
Kintara Therapeutics, Inc., a clinical stage drug development company, focuses on developing and commercializing anti-cancer therapies to treat cancer patients. It is developing two late-stage, Phase III-ready therapeutics, including VAL-083, a DNA-targeting agent for the treatment of drug-resistant solid tumors, such as glioblastoma multiforme, as well as other solid tumors, including ovarian cancer, non-small cell lung cancer, and diffuse intri...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE